Komori
Revision to earnings forecast6849NIHON KOHDEN CORPORATIONElectrical and Precision Instruments

Notice Concerning Revision of Earnings Forecasts

Full-year consolidated earnings forecasts for the fiscal year ending March 2027 were revised downward. Revenue is down 1.7%, operating profit 27.7%, ordinary profit 31.9%, and net income attributable to owners of the parent 30.0%.

Worth reading
75Important
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Deterioration
Direction inferred from the company’s description.
Scale
-31.9
% (ordinary profit)
Wording
Avoiding a definitive answer
How definitive the wording is.

Revised forecast

Fiscal year ending March 2027 · Full yearPrevious forecast published 14 May 2026
Net Sales232,500→228,500Millions of yen
-1.7%
Operating profit23,500→17,000Millions of yen
-27.7%
Ordinary income23,500→16,000Millions of yen
-31.9%
Profit attributable to owners of the parent15,000→10,500Millions of yen
-30.0%
Net income per share93.77→65.61Yen
-30.0%

The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.

Reason for the revision

In Japan, cautious investment in medical equipment continued, while overseas forecasts reflected an expected decline in sales to AED distributors and stagnation in business negotiations due to the situation in the Middle East, as well as the yen's depreciation and the receipt of large orders in Europe. The forecasts were revised because, in addition to lower-than-expected revenue, improvement in the gross profit margin is expected to fall short of assumptions due to rising component prices and price competition for consumables in Japan. The impact of the change in アドテック㈱'s fiscal year-end associated with the reorganisation of the US subsidiary was also reflected.

Previous-period resultsRevenue of ¥235,099 million, operating profit of ¥18,745 million, ordinary profit of ¥22,544 million, net income attributable to owners of the parent of ¥14,513 million, and earnings per share of ¥89.25 (fiscal year ending March 2026)
Consolidated / non-consolidatedConsolidated
Revised forecast
ItemDetails
Net Sales232,500 Millions of yen → 228,500 Millions of yen(-1.7%)
Operating profit23,500 Millions of yen → 17,000 Millions of yen(-27.7%)
Ordinary income23,500 Millions of yen → 16,000 Millions of yen(-31.9%)
Profit attributable to owners of the parent15,000 Millions of yen → 10,500 Millions of yen(-30.0%)
Net income per share93.77 Yen → 65.61 Yen
Fiscal Period CoveredFiscal year ending March 2027
Period CoveredFull year
Publication date of previous forecast14 May 2026
Previous-period resultsRevenue of ¥235,099 million, operating profit of ¥18,745 million, ordinary profit of ¥22,544 million, net income attributable to owners of the parent of ¥14,513 million, and earnings per share of ¥89.25 (fiscal year ending March 2026)
Reason for the revisionIn Japan, cautious investment in medical equipment continued, while overseas forecasts reflected an expected decline in sales to AED distributors and stagnation in business negotiations due to the situation in the Middle East, as well as the yen's depreciation and the receipt of large orders in Europe. The forecasts were revised because, in addition to lower-than-expected revenue, improvement in the gross profit margin is expected to fall short of assumptions due to rising component prices and price competition for consumables in Japan. The impact of the change in アドテック㈱'s fiscal year-end associated with the reorganisation of the US subsidiary was also reflected.
Consolidated / non-consolidatedConsolidated
Items this document does not state (2)
Details and amount of extraordinary lossDividend forecast revision

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

In Japan, cautious investment in medical equipment is expected to continue, while overseas sales to AED distributors are expected to decline and business negotiations are expected to stagnate due to the situation in the Middle East. On the earnings side, the revision is based on the expectation that, in addition to lower-than-expected revenue, improvement in the gross profit margin will fall short of assumptions because of rising component prices and price competition for consumables in Japan.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Concerning Revision of Earnings Forecasts | NIHON KOHDEN CORPORATION (6849) timely disclosure | Komori